LNTH Lantheus Holdings Inc

$58.21

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Updated On 8/22/2025

About Lantheus Holdings Inc

Lantheus Holdings, Inc. develops, manufactures and markets diagnostic and therapeutic agents and products that assist physicians in the diagnosis and treatment of heart, cancer and other diseases worldwide. The company is headquartered in North Billerica, Massachusetts.

Website: https://www.lantheus.com

Sector
LIFE SCIENCES
Industry
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1521036
Address
331 TREBLE COVE ROAD, NORTH BILLERICA, MA, US
Valuation
Market Cap
$6.95B
P/E Ratio
23.24
PEG Ratio
0.61
Price to Book
6.39
Performance
EPS
$4.36
Dividend Yield
Profit Margin
20.40%
ROE
32.80%
Technicals
50D MA
$94.86
200D MA
$98.47
52W High
$126.89
52W Low
$62.59
Fundamentals
Shares Outstanding
69M
Target Price
$134.38
Beta
0.20

LNTH EPS Estimates vs Actual

Estimated
Actual

LNTH News & Sentiment

Aug 22, 2025 • Benzinga SOMEWHAT-BULLISH
Kirby McInerney LLP Announces Investigation Against Lantheus Holdings, Inc. on Behalf of Investors - Lantheus Holdings ( NASDAQ:LNTH )
NEW YORK, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- The law firm of Kirby McInerney LLP is investigating potential claims against Lantheus Holdings, Inc. ( "Lantheus" or the "Company" ) LNTH. The investigation concerns whether Lantheus and/or certain of its officers have violated the federal ...
Aug 21, 2025 • Benzinga NEUTRAL
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lantheus Holdings, Inc. - LNTH - Lantheus Holdings ( NASDAQ:LNTH )
NEW YORK, Aug. 21, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Lantheus Holdings, Inc. ( "Lantheus" or the "Company" ) LNTH. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Aug 20, 2025 • Benzinga SOMEWHAT-BULLISH
Nuclear Medicine Market is expected to generate a revenue of USD 12.99 Billion by 2032, Globally, at 9.30% CAGR: Verified Market Research®
Lewes, Delaware, Aug. 20, 2025 ( GLOBE NEWSWIRE ) -- The Global Nuclear Medicine Market Size is projected to grow at a CAGR of 9.30% from 2026 to 2032, according to a new report published by Verified Market Research®.
Aug 12, 2025 • Benzinga SOMEWHAT-BULLISH
This Union Pacific Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Getty Images Holdings ( NYSE:GETY ) , Cogent Comms Hldgs ( NASDAQ:CCOI )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Jefferies analyst Samad Samana downgraded Open Text Corporation OTEX from Buy to Hold and cut ...
Aug 06, 2025 • Motley Fool NEUTRAL
Lantheus ( LNTH ) Q2 Revenue Falls 4%
Lantheus ( NASDAQ:LNTH ) , a developer of diagnostic and therapeutic radiopharmaceuticals, reported results on August 6, 2025, for Q2 FY2025. In its latest release, the company missed both GAAP revenue and non-GAAP earnings estimates.-reporting GAAP revenue of $378.0 million versus analyst ...
Aug 06, 2025 • Benzinga SOMEWHAT-BULLISH
Nasdaq Surges 1%; Uber Sales Top Estimates - Ainos ( NASDAQ:AIMD ) , Astera Labs ( NASDAQ:ALAB )
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 1% on Wednesday. The Dow traded up 0.30% to 44,242.05 while the NASDAQ gained 1.03% to 21,132.45. The S&P 500 also rose, gaining, 0.72% to 6,344.65. Consumer staples shares jumped by 1.3% on Wednesday.
Sentiment Snapshot

Average Sentiment Score:

0.251
50 articles with scored sentiment

Overall Sentiment:

Bullish

LNTH Reported Earnings

Apr 30, 2025
Mar 31, 2025 (Pre market)
0.0 Surprise
  • Reported EPS: $0.00
  • Estimate: $0.00
  • Whisper:
  • Surprise %: 0.0%
Feb 20, 2025
Dec 31, 2024 (Pre market)
0.05 Surprise
  • Reported EPS: $1.59
  • Estimate: $1.54
  • Whisper:
  • Surprise %: 3.0%
Nov 06, 2024
Sep 30, 2024 (Pre market)
0.14 Surprise
  • Reported EPS: $1.70
  • Estimate: $1.56
  • Whisper:
  • Surprise %: 9.0%
Jul 31, 2024
Jun 30, 2024 (Pre market)
-0.03 Surprise
  • Reported EPS: $1.80
  • Estimate: $1.83
  • Whisper:
  • Surprise %: -1.6%
May 02, 2024
Mar 31, 2024 (Pre market)
0.15 Surprise
  • Reported EPS: $1.69
  • Estimate: $1.54
  • Whisper:
  • Surprise %: 9.7%
Feb 22, 2024
Dec 31, 2023 (Pre market)
0.3 Surprise
  • Reported EPS: $1.75
  • Estimate: $1.45
  • Whisper:
  • Surprise %: 20.7%
Nov 02, 2023
Sep 30, 2023 (Pre market)
0.15 Surprise
  • Reported EPS: $1.47
  • Estimate: $1.32
  • Whisper:
  • Surprise %: 11.4%
Aug 03, 2023
Jun 30, 2023 (Pre market)
0.23 Surprise
  • Reported EPS: $1.54
  • Estimate: $1.31
  • Whisper:
  • Surprise %: 17.6%
May 04, 2023
Mar 31, 2023 (Pre market)
0.21 Surprise
  • Reported EPS: $1.47
  • Estimate: $1.26
  • Whisper:
  • Surprise %: 16.7%

Financials